Since establishing its presence in Egypt in 1977, Otsuka has become a cornerstone of the country’s healthcare sector, exemplifying a successful model of Japanese-Egyptian partnership. The company has built a strong reputation in the production of intravenous solutions and medical nutrition, combining advanced Japanese technology with skilled Egyptian talent.

With continuous investments exceeding EGP 1.5 billion, Otsuka has steadily expanded its operations, most notably with the launch of a state-of-the-art factory dedicated to parenteral nutrition. This expansion not only strengthens the company’s manufacturing capabilities but also enhances Egypt’s capacity to serve regional and international markets.

Recognized for its commitment to high-quality standards and regional export excellence, Otsuka plays a pivotal role in advancing Egypt’s ambition to become a regional hub for pharmaceutical manufacturing. Its operations are closely aligned with the country’s national healthcare reforms and global market needs, underscoring Otsuka’s contribution to both public health and industrial development.